|
08/12/2025 |
Rectal ozone therapy in patients with joint symptoms following the acute phase of Chikungunya. |
CPN |
Registered |
|
04/12/2025 |
Evaluation of the possible protective effect of Curmeric on the clinical evolution of patients in the post-acute and chronic period of Chikungunya disease |
CEADEN |
Registered |
|
19/11/2025 |
Safety and therapeutic effect of administration of Jusvinza in the post-acute stage of Chikungunya infection |
CIGB |
Registered |
|
17/11/2025 |
Safety and therapeutic effect of administration of Jusvinza in the chronic stage of Chikungunya infection |
CIGB |
Registered |
|
17/11/2025 |
Anti-PD1 2C12 in adult patients with advanced non-small cell lung cancer and unresectable or metastatic melanoma. Phase I-II |
CIM |
Registered |
|
17/11/2025 |
Evaluation of the satiating and probiotic effect of goat cheese in volunteers on a weight control regimen: A randomized controlled trial |
SSA |
Registered |
|
12/08/2025 |
Efficacy and safety of the monoclonal antibody nimotuzumab plus FOLFOX vs. FOLFOX as first-line treatment of patients with unresectable, left-sided, metastatic colorectal cancer. Phase I/II |
CIM |
Registered |
|
16/07/2025 |
Evaluation of safety and tolerability of JM-20 with healthy volunteers. Clinical trial Phase I. |
CIDEM |
Registered |
|
10/06/2025 |
Effects of the Adiponexin formulation on the composition of the intestinal microbiome and weight regulation in individuals with a Body Mass Index greater than or equal to 25 |
HHA |
Registered |
|
30/04/2025 |
Effect of the high-precision symbiotic formulation OptiGutPro EDC-HHA02 in treatment of Idiopathic Inflammatory Bowel Disease |
HHA |
Registered |
|
24/03/2025 |
CIMAvax®-EGF in patients with moderate-severe chronic obstructive pulmonary disease (COPD) |
CIM |
Registered |
|
07/03/2025 |
Prevenox Plus versus original Prevenox: Comparison of effects in healthy volunteers |
CPN |
Registered |
|
13/02/2025 |
Nasalferon in respiratory infections in adults. Phase 3 clinical trial. |
CIGB |
Registered |
|
12/02/2025 |
Intranasal chlorpheniramine (0.4%) for the perennial allergic rhinitis (AR) treatment in adults. Phase IV. |
Ferrer |
Registered |
|
27/12/2024 |
Phase II-III study to evaluate the safety and immunogenicity of the pneumococcal vaccine candidate VCN11 in adult participants aged 50 to 74 years. |
FINLAY |
Registered |
|
12/12/2024 |
Efficacy and safety of SURFACEN® administration by tracheal catheterization in preterm neonates with respiratory distress syndrome. Phase II/III |
CENSA |
Registered |
|
04/11/2024 |
Evaluation of the safety and the therapeutic effect of the Guanabana infusion in patients with breast cancer |
SSA |
Registered |
|
06/09/2024 |
Evaluation of the effect and safety of a booster dose of Abdala against COVID-19. |
CIGB |
Registered |
|
22/08/2024 |
Safety and effect of Itolizumab in extracorporeal circulation, phase I/II |
CIM |
Registered |
|
21/08/2024 |
Phase II-III clinical trial to evaluate the vaccine candidate against pneumococcal diseases VCN11 in infants |
FINLAY |
Registered |
